Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure

European Journal of Echocardiography

Volumn 10, Issue 8, 2009, Pages 968-974

  Valle Muñoz, Alfonso ^a   Estornell Erill, Jordi ^a   Soriano Navarro, Carlos J ^a   Nadal Barange, Mercedes ^a   Martinez Alzamora, Nieves ^b   Pomar Domingo, Francisco ^a   Corbí Pascual, Miguel ^a   Payá Serrano, Rafael ^a   Ridocci Soriano, Francisco ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Acute heart failure; Cardiovacular magnetic resonance; Diagnostic value; Ischaemic cardiomyopathy; Late gadolinium enhancement

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70449627507     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jep115     Document Type: Article

References (26)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2008;29:2388-2442
2. Gunnarsson G, Eriksson P, Dellborg M. ECG criteria in diagnosis of acute myocardial infarction in the presence of left bundle branch block. Int J Cardiol 2001;78:167-174
3. Bashore TM, Bates ER, Berger PB, Clark DA, Cusma JT, Dehmer GJ et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:2170-2214
4. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP et al. A survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-2736
5. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59
6. Casolo G, Minneci S, Manta R, Sulla A, Del Meglio J, Rega L et al. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. Am Heart J 2006;151:101-108
7. Soriano CJ, Ridocci F, Estornell J, Jiménez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using Late gadolinium-enhanced cardiovascular magnetic resonance. J Am coll Cardiol 2005;45:743-748
8. Mahrlholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischemic cardiomyopaties. Eur Heart J 2005;26:1461-1474 (Pubitemid 41373486)
9. Ridocci F, Soriano CJ, Estornell J. Imaging approach to the assessment of cardiomyopathies using delayed enhancement cardiovascular magnetic resonance. (Letter). Eur Heart J 2005;26:2601-2602
10. Schietinger BJ, Voros S, Isbell DC, Meyer CH, Christopher JM, Kramer CM. Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure? Int J Cardiovasc Imaging 2007;23:595-602.
11. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined- a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969 (Pubitemid 30681627)
12. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM et al. An improved magnetic resonance imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223
13. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105: 539-542
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
15. ZweigMH,Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577
16. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley and Sons; 1981.
17. Soriano CJ, Ridocci F, Estornell J, Pérez-Boscá JL, Pomar F, Trigo A et al. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. Int J Cardiol 2007;116:167-173
18. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of the presence, location and transmural extent of healed Q-wave and non Q-wave myocardial infarction. Lancet 2001;357:21-28
19. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453
20. Rahimtoola SH. Concept and evaluation of hibernating myocardium. Annu Rev Med 1999;50:75-86.
21. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2.920-31.
22. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580
23. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113: 2733-2743
24. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:2414-2421
25. Valle A, Corbi M, Nadal M. Prognostic implications of ischemic myocardial scar by cardiac magnetic resonance in patients with normal coronary angiography and dilated cardiomyopathy (Abstract). Circulation 2008; 118: S839.
26. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-1985